Indomethacin vs pancreatic stent to prevent post-ERCP pancreatitis
Treatments studied
Part of Digestive system clinical trials.
This study compares indomethacin (an anti-inflammatory medicine) against using a temporary pancreatic stent to prevent pancreatitis after an ERCP procedure. It may help you lower the chance of painful inflammation of the pancreas after ERCP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having an ERCP soon and have at least one risk factor for post-ERCP pancreatitis
- Your risk factor can include prior pancreatitis after ERCP, difficult access with many attempts, or other listed features
- You do not already need a pancreatic stent for another reason (like pancreatic duct narrowing or ampullectomy)
- You must be age 18 or older and able to give informed consent
- You cannot be pregnant or breastfeeding
- You should not have a reason you cannot take NSAIDs (like indomethacin), such as active stomach bleeding, kidney failure, NSAID allergy, or early heart failure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a low dose of indomethacin (a pain reliever) with the standard dose to see if it works just as well for preventing pancreatitis (inflammation of the pancreas) after an ERCP procedure. It may reduce side effects while still protecting your pancreas.
This study tests whether a rectal dose of indomethacin (an anti-inflammatory drug) can help prevent complications after an ERCP. It is for people who have already had a sphincterotomy and are having another ERCP to treat bile duct issues.
This study tests giving indomethacin (a type of anti-inflammatory medicine) through the rectum in different doses to people having an ERCP (a procedure to look at bile and pancreas tubes), aiming to prevent a common complication called post-ERCP pancreatitis (inflammation of the pancreas). You may join if you are at high risk for this complication and meet the other health requirements.
This trial tests placing a small plastic tube (stent) in your pancreatic duct early during ERCP to try to prevent pancreatitis (inflammation of the pancreas). It’s for people having their first ERCP to get into their bile duct.
This trial tests whether giving extra IV fluids before, during, and after an ERCP procedure can help prevent a common complication called post-ERCP pancreatitis (inflammation of the pancreas). If you are scheduled for an ERCP, you may be eligible to participate.
This study looks at a small plastic tube placed in the pancreas during an ERCP procedure to see if it helps prevent a painful complication called post-ERCP pancreatitis. It aims to understand if the tube stays in place and if it causes any problems.
Hear when a new Post-ERCP Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.